![Stephen Thomas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen Thomas
Direktor/Vorstandsmitglied bei ELIEM THERAPEUTICS, INC.
Vermögen: 801 123 $ am 31.05.2024
Aktive Positionen von Stephen Thomas
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ELIEM THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 27.06.2024 | - |
Ichorion Therapeutics, Inc.
![]() Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY. | Gründer | 07.07.2017 | - |
Karriereverlauf von Stephen Thomas
Statistik
International
Vereinigte Staaten | 2 |
2 |
Operativ
Founder | 1 |
Director/Board Member | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Ichorion Therapeutics, Inc.
![]() Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY. | Health Technology |
Eliem Therapeutics, Inc. |
- Börse
- Insiders
- Stephen Thomas
- Erfahrung